In 2023, the sales of Obstructive Airway Diseases Medicine in Belgium stood at 315.3 million Euros. The forecasted data shows an upward trend from 2024 to 2028, with sales rising from 321.1 million Euros to 344.3 million Euros. The year-on-year growth rates are approximately 1.8% for 2024, 1.8% for 2025, 1.8% for 2026, and 1.7% for 2027, reflecting a steady growth pattern. The Compound Annual Growth Rate (CAGR) over the five-year period from 2023 to 2028 is approximately 1.8%, indicating consistent development in this market.

Future trends to watch for include:

Advancements in medical treatments and technology for airway diseases.
Increasing prevalence of respiratory conditions due to environmental factors.
Government policies and healthcare reforms impacting accessibility and affordability of medicines.